GTC
BEAT

Ghost Tree Capital’s BioTelemetry, Inc. BEAT Stock Holding History

Ghost Tree Capital’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-125,000
Closed -$993K – 95
2013
Q4 		$993K Buy
+125,000
New +$1.17M 0.61% 48

Other funds holding BEAT

CPIM
Columbia Partners Investment Management Alexandria, Virginia $257M AUM 8.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
SC
Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ghost Tree Capital's BEAT Position: Q1 2014 in Review

Ghost Tree Capital sold out of BioTelemetry, Inc. (BEAT) in Q1 2014, closing a stake of 125,000 shares — an estimated $993K sold.

Ghost Tree Capital first reported a position in BEAT in Q4 2013 and held it in 1 quarter. The position peaked at $993K in Q4 2013. 83 funds tracked by Wall St. Rank hold BEAT as of Q1 2014.

  • Ghost Tree Capital reported no remaining BioTelemetry, Inc. position as of Q1 2014 after selling out during the quarter.
  • Ghost Tree Capital sold 125,000 BioTelemetry, Inc. shares in Q1 2014, an estimated $993K.
  • Ghost Tree Capital first reported a position in BioTelemetry, Inc. in Q4 2013 and held it in 1 quarter.
  • Ghost Tree Capital's BioTelemetry, Inc. position peaked at $993K in Q4 2013.
  • 83 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2014.

Based on Ghost Tree Capital's 13F filing for Q1 2014, filed 15 May 2014.